SCHEMBL10006847

SCHEMBL10006847

CCCCc1ncc2c(n1)n(C)c(=O)n2C(=O)N(C)CC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.33
▸ TAS2R14 Q9NYV8 1/20 0.32
▸ MAPT P10636 3/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ XDH P47989 1/20 0.31
▸ GRIN1 Q05586 3/20 0.30
▸ GRIN2B Q13224 3/20 0.30
▸ PDE4A P27815 3/20 0.30
▸ LMNA P02545 1/20 0.30
▸ ESR1 P03372 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ NFKB1 P19838 1/20 0.30
▸ ACHE P22303 1/20 0.30
▸ BLM P54132 1/20 0.30
▸ PMP22 Q01453 1/20 0.30
▸ ADORA2A P29274 3/20 0.30
▸ ADORA2B P29275 2/20 0.30
▸ PDE4B Q07343 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10006762 0.84 TLR7 (0.39) MEN1KMT2AMAPTADORA2AADORA1
SCHEMBL10007102 0.84 ALDH1A1 (0.36) MEN1KMT2AALDH1A1TAS2R14MAPT
SCHEMBL10267698 0.82 TAS2R14 (0.41) TAS2R14GRIN1GRIN2BADORA2BTSPO
SCHEMBL10006781 0.81 TSPO (0.40) MEN1KMT2AALDH1A1SMN1; SMN2NFKB1
SCHEMBL12830371 0.81 TAS2R14 (0.34) MEN1KMT2ATAS2R14SMN1; SMN2GRIN1
SCHEMBL10267641 0.81 GRIN1 (0.35) TAS2R14GRIN1GRIN2BLMNAADORA2B
SCHEMBL10006851 0.81 TRPV1 (0.36) ALDH1A1TAS2R14MAPTSMN1; SMN2GRIN1
SCHEMBL10292527 0.80 MAOB (0.36) ALDH1A1MAPTSMN1; SMN2GRIN1GRIN2B
SCHEMBL10006926 0.80 GAA (0.36) ALDH1A1MAPTSMN1; SMN2GRIN1GRIN2B
SCHEMBL10262126 0.80 GRIN1 (0.36) ALDH1A1TAS2R14SMN1; SMN2GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2476682-B1 8-OXODIHYDROPURINE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2017-04-26 — — EP disclosed
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
EP-2476682-A1 8-OXODIHYDROPURINE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2012-07-18 — — EP disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE FAAH, FAAH2, TPMT MEN1 4651/4885KMT2A 769/4885ALDH1A1 50/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback